PBMs administer prescription drug plans for more than 266 million Americans. With the costs and complexity of specialty drug treatments rising, PBMs offer a number of services designed to improve the quality of care for patients across the nation while managing overall costs to the health care system. To encourage complete coordination across the continuum of patient care, payers depend on PBMs’ utilization management tools, including the use of specialty pharmacies, to ensure that the value of therapy is optimized, at the most reasonable costs possible.
The rapid and ever-changing growth of the specialty pharmacy industry presents a multitude of challenges and opportunities for the health care industry. sPCMA was established as a division of PCMA to provide thought leadership and advocacy to the industry on matters of public policy, industry relations, and the value of specialty pharmacies. sPCMA:
- Defines and promotes the value of specialty pharmacy;
- Illuminates emerging policy issues affecting the industry;
- Serves as a public voice on matters related to specialty pharmacy; and
- Provides a forum for members to engage opinion leaders, policymakers, and other authorities.
Board of Directors
sPCMA does not provide medical advice, diagnosis, treatment, or prescriptions. Any health information services, suggestions, or other content on sPCMA are for informational purposes only. Users assume full responsibility for the use of information obtained through the site and agree to not hold sPCMA responsible or liable for any claim, loss, or damage arising from using the information.